PD-L1 targeting antibodies (Euchloe Bio)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePD-L1 targeting antibodies (Euchloe Bio)
Drug Alias NamePD-L1 checkpoint inhibitor (Euchloe Bio)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEuchloe Bio Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEuchloe Bio Pte Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A